Glaucoma is a heterogeneous disease, and genetic risk for glaucoma is complex and extends well beyond myocilin, but patients with the highest combination of known genetic risk variants are diagnosed on average 5 years earlier than those with fewer genetic risk variants (Fan et al., 2019). The gene discussed is MYOC; the disease is glaucoma.